Article
Collateral sensitivities with predictive signatures emerge in a novel model of evolved chemoresistance in osteosarcoma
2026-08-11
Abstract excerpt
Osteosarcoma (OS) is the most common primary malignant bone tumor in children and adolescents. Despite aggressive multimodal therapy, including surgery and chemotherapy with methotrexate, doxorubicin, and cisplatin (MAP), outcomes for patients with relapsed or refractory disease remain poor, with no standardized second-line regimen. We developed a clinically calibrated, temporally resolved in vitro model to exami...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f9c15ad1-848a-5798-a858-63deb46f2137
- DOI
- 10.64898/2026.08.10.743977
